What happens when healthcare organisations try to detect drug diversion without integrated identity and device data?

Why missing identity and device context breaks diversion detection

Drug diversion detection depends on joining medication events to the person, device, and clinical context behind them. Without that join, alerts are based on partial signals, so a legitimate handoff can look suspicious and a suspicious pattern can look normal. The main problem is not just missed events, but missed explanation, which makes it harder to separate workflow variation from true misuse.

That is especially true when organisations rely on isolated feeds from medication cabinets, dispensing systems, EHRs, and device logs. A scan of who authenticated, which workstation or device was used, and whether the access pattern matches the care setting is what turns a raw event stream into a defensible investigative record.

Integrated identity data is the bridge between access and accountability. When access records are disconnected from clinical identity, teams cannot easily tell whether the same user repeatedly touched controlled substances, whether shared credentials obscured the actor, or whether access happened from an unexpected endpoint. NHIMG’s Healthcare Identity Security Guide is useful here because it treats clinician access, shared workstations, EPCS, and medical devices as a single operational control problem.

How device data changes the investigation

Device context helps distinguish normal clinical movement from behavior that deserves review. In healthcare settings, the same medication action can look very different depending on whether it came from a trusted workstation, a shared cart, a bedside device, or a system that is not normally used for that workflow. device identity, posture, and location do not prove diversion on their own, but they provide the context needed to interpret the event correctly.

Without device data, investigators often have to infer too much from timestamps and user IDs alone. That slows triage because the team must manually reconstruct whether the access happened from an approved device, whether multiple users shared the same endpoint, or whether the device itself was outside expected control boundaries. NHIMG’s Device and IoT Identity Guide is relevant because it explains how device identity, certificates, attestation, and lifecycle controls support trust in device-originated activity.

This is also why SPIFFE workload identity concepts matter conceptually even outside traditional infrastructure teams: the core lesson is that you need a reliable way to know which trusted actor or endpoint produced the action before you can trust the event trail.

What good detection looks like in practice

Good diversion monitoring does not treat a medication event as a standalone alert. It correlates access, time, device, location, role, and workflow expectations so the organisation can answer a simple question: does this activity fit the care context or not? That is why integrated monitoring usually produces fewer, better alerts rather than more alerts.

For healthcare organisations, the practical goal is not to catch every anomaly automatically. It is to reduce false reassurance. A monitoring programme is only useful if it can show who performed the action, from what device, under what clinical context, and whether the access pattern is explainable without manual guesswork. NHIMG’s Identity Data Quality and Identity Fabric Guide supports this point because it focuses on authoritative sources, correlation, and identity data quality as the basis for trustworthy decisions.

Healthcare teams also benefit from a broader view of identity signals. NHIMG’s Identity Visibility and Intelligence Platforms (IVIP) Guide is relevant because it explains why unified identity visibility is what turns scattered events into actionable detection and investigation.

Risk and Threat Considerations

When identity and device data are not correlated, diversion monitoring becomes easy to evade and hard to defend. Shared credentials, borrowed workstations, delayed log review, and missing endpoint context can all hide the real actor behind a medication access event, which creates both detection gaps and accountability gaps.

Failure mechanism: The organisation sees medication activity as isolated system events instead of a linked chain of actor, device, and workflow evidence, so suspicious behavior is filtered out as routine variance or cannot be attributed confidently.

Impact: Real diversion can persist longer, investigators spend more time reconstructing basic facts, and compliance evidence becomes weaker because the monitoring record cannot reliably explain who did what, from where, and under what conditions.

Practitioner Guidance

What to verify: Before trusting diversion alerts, verify that the alerting path can correlate medication access to a unique identity, a specific device, and a clinical workflow context. If any one of those links is missing, treat the result as an incomplete signal rather than a true negative.

Decision rule: If the investigation cannot distinguish a shared workstation, shared credential, or unexpected endpoint from a normal clinician session, prioritise data integration and attribution quality before tuning alert thresholds.

Practitioner takeaway: In diversion detection, more telemetry is not the same as better detection. The control only becomes meaningful when identity and device evidence are joined tightly enough to support attribution, workflow validation, and audit-ready explanations.

Related resources from NHI Mgmt Group

• What happens when healthcare organisations try to share sensitive data without a unified identity layer?
• What happens when healthcare organisations try to manage ePHI without a complete view of apps, data flows, and access methods?
• What happens when organisations try to enforce zero trust without integrated identity stores?
• What happens when healthcare organisations try to protect intellectual property without data visibility and monitoring?